These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30565491)

  • 1. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    Mod Rheumatol; 2019 Jan; 29(1):1-19. PubMed ID: 30565491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    J Dermatol; 2019 Jan; 46(1):e1-e18. PubMed ID: 30562845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
    Ann Rheum Dis; 2017 May; 76(5):792-801. PubMed ID: 28385805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
    Arthritis Rheumatol; 2017 May; 69(5):898-910. PubMed ID: 28382787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using multi-omics methods to understand dermatomyositis/polymyositis.
    Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
    Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update.
    Kobayashi I; Akioka S; Kobayashi N; Iwata N; Takezaki S; Nakaseko H; Sato S; Nishida Y; Nozawa T; Yamasaki Y; Yamazaki K; Arai S; Nishino I; Mori M
    Mod Rheumatol; 2020 May; 30(3):411-423. PubMed ID: 31955618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
    Wu C; Wang Q; He L; Yang E; Zeng X
    PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population.
    Bradford Rice J; White A; Lopez A; Galebach P; Schepman P; Popelar B; Philbin M
    J Med Econ; 2016 Jul; 19(7):649-54. PubMed ID: 26850074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.
    Sunderkötter C; Nast A; Worm M; Dengler R; Dörner T; Ganter H; Hohlfeld R; Melms A; Melzer N; Rösler K; Schmidt J; Sinnreich M; Walter MC; Wanschitz J; Wiendl H
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):321-38. PubMed ID: 26972210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
    Rider LG; Ruperto N; Pistorio A; Erman B; Bayat N; Lachenbruch PA; Rockette H; Feldman BM; Huber AM; Hansen P; Oddis CV; Lundberg IE; Amato AA; Chinoy H; Cooper RG; Chung L; Danko K; Fiorentino D; García-De la Torre I; Reed AM; Wook Song Y; Cimaz R; Cuttica RJ; Pilkington CA; Martini A; van der Net J; Maillard S; Miller FW; Vencovsky J; Aggarwal R;
    Rheumatology (Oxford); 2017 Nov; 56(11):1884-1893. PubMed ID: 28977549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Saad Magalhaes C; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
    Ann Rheum Dis; 2017 May; 76(5):782-791. PubMed ID: 28385804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus-based recommendations for the management of juvenile dermatomyositis.
    Bellutti Enders F; Bader-Meunier B; Baildam E; Constantin T; Dolezalova P; Feldman BM; Lahdenne P; Magnusson B; Nistala K; Ozen S; Pilkington C; Ravelli A; Russo R; Uziel Y; van Brussel M; van der Net J; Vastert S; Wedderburn LR; Wulffraat N; McCann LJ; van Royen-Kerkhof A
    Ann Rheum Dis; 2017 Feb; 76(2):329-340. PubMed ID: 27515057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan.
    Kawasumi H; Gono T; Kawaguchi Y; Kuwana M; Kaneko H; Katsumata Y; Kataoka S; Hanaoka M; Yamanaka H
    Biomed Res Int; 2016; 2016():9163201. PubMed ID: 26925419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
    Hinze CH; Oommen PT; Dressler F; Urban A; Weller-Heinemann F; Speth F; Lainka E; Brunner J; Fesq H; Foell D; Müller-Felber W; Neudorf U; Rietschel C; Schwarz T; Schara U; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):40. PubMed ID: 29940960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dermatomyositis and polymyositis.
    Choy EH; Isenberg DA
    Rheumatology (Oxford); 2002 Jan; 41(1):7-13. PubMed ID: 11792873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis.
    Alexanderson H; Lundberg IE
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):153-8. PubMed ID: 18021522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dermatomyositis and polymyositis: 21 cases in Senegal].
    Diallo M; Fall AK; Diallo I; Diédhiou I; Ba PS; Diagne M; Ndiaye B; Ndiaye A; Niang A; Gning SB; Ba FK; Fall F; Mbaye PS
    Med Trop (Mars); 2010 Apr; 70(2):166-8. PubMed ID: 20486354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and incidence of polymyositis and dermatomyositis in Japan.
    Ohta A; Nagai M; Nishina M; Tomimitsu H; Kohsaka H
    Mod Rheumatol; 2014 May; 24(3):477-80. PubMed ID: 24252012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
    Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
    Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.